Stocks
BioRestorative Therapies, Inc.BRTX
NASDAQHealthcareBiotechnology$1.62
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing stem cell therapies for metabolic and orthopedic disorders, including its lead candidate for chronic lower back pain. Investors track it for its pipeline progress and potential in regenerative medicine.
52W Range: $1.28-$34.00
Congressional Interest in BioRestorative Therapies, Inc. (BRTX)
No congressional trades have been disclosed for BioRestorative Therapies, Inc. (BRTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading BRTX?
No congressional trades found for this stock.